GlassScriptPhysician profile
Amanda R Hill
NPI 1801238852
$5,297.10
in general payments reported to CMS, 2019-2025
32 companies · $1,593 in 2025
The $1,593 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $799 · 2021: $88.04 · 2022: $393 · 2023: $697 · 2024: $1,728 · 2025: $1,593.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,813 · Education: $204.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,812.77 |
| Education | $204.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,369.54 | 2019-2025 | Rinvoq, Botox |
| Regeneron Healthcare Solutions, INC. | $424.18 | 2022-2025 | Dupixent, Libtayo |
| Galderma Laboratories, L.P. | $402.72 | 2019-2025 | Nemluvio, Aklief, Oracea |
| Janssen Biotech, INC. | $354.03 | 2023-2025 | Tremfya, Stelara, Simponi |
| Pfizer INC. | $268.75 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $234.17 | 2023-2025 | |
| Incyte Corporation | $226.77 | 2021-2024 | Opzelura |
| Sun Pharmaceutical Industries INC. | $206.02 | 2019-2025 | Absorica Ld, Winlevi |
| E.R. Squibb & Sons, L.L.C. | $195.41 | 2023-2025 | Sotyktu |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $180.93 | 2019-2024 | Siliq |
| Genzyme Corporation | $171.52 | 2023-2024 | |
| Musculoskeletal Transplant Foundation INC. | $164.56 | 2025 | |
| Organon LLC | $140.76 | 2023-2025 | Hadlima, Vtama |
| Convatec INC. | $139.30 | 2025 | |
| Amgen INC. | $108.52 | 2023-2025 | Otezla, Otezla |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $91.00 | 2019 | |
| Dermavant Sciences, INC. | $79.97 | 2024 | Vtama |
| Allergan, INC. | $75.37 | 2019 | |
| Arcutis Biotherapeutics, INC. | $68.16 | 2024-2025 | Zoryve |
| Lilly USA, LLC | $67.99 | 2023-2024 | Taltz, Olumiant, Ebglyss |
| Boehringer Ingelheim Pharmaceuticals, INC. | $60.07 | 2023-2024 | Spevigo, Cyltezo |
| Leo Pharma INC. | $60.01 | 2022-2025 | Adbry, Anzupgo |
| Dermira, INC. | $32.67 | 2019 | |
| Mayne Pharma Commercial LLC | $23.21 | 2019 | |
| Organogenesis INC. | $21.32 | 2024 | |
| Medline Industries LP | $20.83 | 2025 | |
| Bausch Health US, LLC | $20.71 | 2021 | |
| Boston Scientific Corporation | $20.20 | 2025 | General - Therapies |
| Ucb, INC. | $19.41 | 2023 | Cimzia |
| Verrica Pharmaceuticals INC. | $16.70 | 2025 | Ycanth |
| Mentor Worldwide LLC | $16.64 | 2019 | |
| Almirall LLC | $15.66 | 2024 | Seysara |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Hill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.